Symbol="KYMR"
AssetType="Common Stock"
Name="Kymera Therapeutics Inc"
Description="Kymera Therapeutics, Inc., a biopharmaceutical company, is focused on discovering and developing new small molecule treatments that selectively break down disease-causing proteins by harnessing the body's own natural protein breakdown system. The company is headquartered in Watertown, Massachusetts."
CIK="1815442"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)"
Address="300 TECHNOLOGY SQUARE, 2ND FLOOR, CAMBRIDGE, MA, US"
FiscalYearEnd="December"
LatestQuarter="2023-06-30"
MarketCapitalization="1320750000"
EBITDA="-167680000"
PERatio="None"
PEGRatio="None"
BookValue="8.95"
DividendPerShare="0"
DividendYield="0"
EPS="-2.85"
RevenuePerShareTTM="0.868"
ProfitMargin="0"
OperatingMarginTTM="0"
ReturnOnAssetsTTM="-0.18"
ReturnOnEquityTTM="-0.357"
RevenueTTM="46670000"
GrossProfitTTM="-117422000"
DilutedEPSTTM="-2.85"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="-0.016"
AnalystTargetPrice="54.59"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="33.3"
PriceToBookRatio="3.168"
EVToRevenue="25.24"
EVToEBITDA="-7.69"
Beta="1.486"
num_52WeekHigh="39.85"
num_52WeekLow="18.84"
num_50DayMovingAverage="24.15"
num_200DayMovingAverage="28.79"
SharesOutstanding="55308000"
DividendDate="None"
ExDividendDate="None"
symbol="KYMR"
open="23.82"
high="23.87"
low="22.25"
price="22.57"
volume="320840.00"
latest_trading_day="2023-08-04"
previous_close="23.88"
change="-1.31"
change_percent="-5.4858%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="82"
trend_strength="Absent or Weak Trend"
buying_signal="Strong Sell Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="18"
Volume_recent_avg="483974"
Change_recent_avg="-0.08"
Delta_recent_avg="1.39"
Variance_recent_avg="0.69"
Change_ratio_recent_avg="-0.39"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="18"
Aroon_momentum_negative="82"
image_negative_thumbnail_id_1="1162"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0196.jpeg"
image_negative_thumbnail_id_2="513"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0092.jpeg"
image_neutral_thumbnail_id_1="554"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0045.jpeg"
image_neutral_thumbnail_id_2="552"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0047.jpeg"
image_positive_thumbnail_id_1="603"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0105.jpeg"
image_positive_thumbnail_id_2="994"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0156.jpeg"
image_professor_thumbnail_id_1="1184"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0018.jpeg"
image_professor_thumbnail_id_2="1168"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0002.jpeg"
